Literature DB >> 17326762

The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.

E G M Berkhoff1, M M Geelhoed-Mieras, E J Verschuren, C A van Baalen, R A Gruters, R A M Fouchier, A D M E Osterhaus, G F Rimmelzwaan.   

Abstract

In the present study, we examined the effect of the loss of the human leucocyte antigen (HLA)-B*3501-restricted nucleoprotein (NP)(418-426) epitope on interferon (IFN)-gamma-production and lytic activity of the human cytotoxic T lymphocyte (CTL) response in vitro. Extensive amino acid variation at T cell receptor contact residues of the NP(418-426) epitope has led to repeated evasion from specific CTL. We generated recombinant influenza viruses with variants of the NP(418-426) epitope, which were used to stimulate peripheral blood mononuclear cells obtained from six HLA-B*3501-positive study subjects in order to expand virus-specific CTL. Loss of the NP(418-426) epitope resulted in a significant reduction of IFN-gamma-expressing CD8+ T cells, similar to that observed previously after the loss of the HLA-B*2705-restricted NP(383-391) epitope. In addition, the effect of the loss of the NP(418-426) epitope on the lytic activity of the virus-specific CTL response was assessed. Also this functional property of the virus-specific CTL response was affected significantly by the loss of this and the NP(383-391) epitope, as determined using the newly developed fluorescent antigen-transfected target cell (FATT)-CTL assay. These findings indicate that the loss of single immunodominant epitopes affects the functionality of the virus-specific CTL response significantly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326762      PMCID: PMC1868867          DOI: 10.1111/j.1365-2249.2007.03340.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

1.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.

Authors:  H Pircher; D Moskophidis; U Rohrer; K Bürki; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

2.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

Authors:  L G Guidotti; T Ishikawa; M V Hobbs; B Matzke; R Schreiber; F V Chisari
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

3.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments.

Authors:  Emmie de Wit; Monique I J Spronken; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

6.  Virus escape from CTL recognition.

Authors:  R A Koup
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

7.  Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.

Authors:  B S Bender; T Croghan; L Zhang; P A Small
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

8.  Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.

Authors:  F Gotch; A McMichael; G Smith; B Moss
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

9.  T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.

Authors:  P O de Campos-Lima; V Levitsky; J Brooks; S P Lee; L F Hu; A B Rickinson; M G Masucci
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  15 in total

1.  Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

Authors:  Carolien E van de Sandt; Mark R Pronk; Carel A van Baalen; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

2.  Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.

Authors:  Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 3.  Immunity to seasonal and pandemic influenza A viruses.

Authors:  Sophie A Valkenburg; John A Rutigliano; Ali H Ellebedy; Peter C Doherty; Paul G Thomas; Katherine Kedzierska
Journal:  Microbes Infect       Date:  2011-02-02       Impact factor: 2.700

4.  NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets.

Authors:  Bin Zhou; Yan Li; Jessica A Belser; Melissa B Pearce; Mirco Schmolke; Anju X Subba; Zhengli Shi; Sherif R Zaki; Dianna M Blau; Adolfo García-Sastre; Terrence M Tumpey; David E Wentworth
Journal:  Vaccine       Date:  2010-10-08       Impact factor: 3.641

Review 5.  Immunological assessment of influenza vaccines and immune correlates of protection.

Authors:  Adrian Reber; Jacqueline Katz
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

6.  Targets for the induction of protective immunity against influenza a viruses.

Authors:  Rogier Bodewes; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  Viruses       Date:  2010-01-14       Impact factor: 5.818

Review 7.  Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.

Authors:  Marine L B Hillaire; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Biomed Biotechnol       Date:  2011-10-05

8.  Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.

Authors:  Irina Isakova-Sivak; Victoria Matyushenko; Tatiana Kotomina; Irina Kiseleva; Elena Krutikova; Svetlana Donina; Andrey Rekstin; Natalia Larionova; Daria Mezhenskaya; Konstantin Sivak; Arman Muzhikyan; Anastasia Katelnikova; Larisa Rudenko
Journal:  Vaccines (Basel)       Date:  2019-07-08

Review 9.  Evasion of influenza A viruses from innate and adaptive immune responses.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Guus F Rimmelzwaan
Journal:  Viruses       Date:  2012-09-03       Impact factor: 5.048

Review 10.  Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.

Authors:  E Bridie Clemens; Carolien van de Sandt; Sook San Wong; Linda M Wakim; Sophie A Valkenburg
Journal:  Vaccines (Basel)       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.